{
  "url": "https://openlegislation.uk/national-health-service-pharmaceutical-and-local-pharmaceutical-services-regulations-2013/schedule-7/paragraph-21",
  "json_url": "https://openlegislation.uk/national-health-service-pharmaceutical-and-local-pharmaceutical-services-regulations-2013/schedule-7/paragraph-21.json",
  "legislation": "uksi/2013/349",
  "legislation_title": "The National Health Service (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013",
  "legislation_url": "https://openlegislation.uk/national-health-service-pharmaceutical-and-local-pharmaceutical-services-regulations-2013",
  "path": "schedule/7/paragraph/21",
  "kind": "paragraph",
  "number": "21",
  "heading": "Dispute resolution: non-NHS contracts",
  "text": "(1) In the case of an LPS scheme that is not an NHS contract, any dispute arising out of or in connection with the scheme, except matters dealt with under the complaints procedure pursuant to paragraph 25, may be referred for consideration and determination to the Secretary of State—\n(a) if it relates to a period when the contractor was treated as a health service body, by the contractor or by NHS England; or\n(b) in any other case, by the contractor or, if the contractor agrees in writing, by NHS England.\n(2) In the case of a dispute referred to the Secretary of State under sub-paragraph (1)—\n(a) the procedure to be followed is the NHS dispute resolution procedure; and\n(b) the parties must agree to be bound by any determination made by the adjudicator.",
  "extent": "E+W+S+N.I.",
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "F",
      "label": "F1",
      "text": "Sch. 7 para. 21(1) substituted (1.3.2015) by The National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Amendment and Transitional Provision) Regulations 2015 (S.I. 2015/58), regs. 1(1), 9 (with reg. 10)"
    },
    {
      "type": "F",
      "label": "F2",
      "text": "Words in Regulations substituted (6.11.2023) by The Health and Care Act 2022 (Further Consequential Amendments) (No. 2) Regulations 2023 (S.I. 2023/1071), reg. 1(1), Sch. para. 1"
    }
  ],
  "outstanding_effects": [
    {
      "type": "inserted",
      "affecting": "uksi/2026/961",
      "affecting_title": "The National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Amendment) (No. 2) Regulations 2026"
    }
  ],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2013/349/schedule/7/paragraph/21",
    "retrieved_at": "2026-10-29T01:03:55.705659+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}